Announcements Trials
Browse Landscape

Phase

Phase 2/3 1Phase 1 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Glioblastoma 15Brain Neoplasms 15Glioma 9Neoplasms 6Carcinoma, Non-Small-Cell Lung 6Neoplasms by Site 5Neoplasms by Histologic Type 5Hematologic Neoplasms 5Recurrence 4Neuroblastoma 4Astrocytoma 4Spinal Cord Neoplasms 3Lymphoproliferative Disorders 3Lung Neoplasms 3Colorectal Neoplasms 3Thyroid Carcinoma, Anaplastic 2Thyroid Cancer, Papillary 2Ovarian Neoplasms 2Oligodendroglioma 2Neurofibromatosis 1 2Neoplasm Metastasis 2Multiple Myeloma 2Melanoma 2Medulloblastoma 2Lymphoma 2Laryngeal Neoplasms 2Erdheim-Chester Disease 2Central Nervous System Neoplasms 2cyclopia sequence 1Vitamin D Deficiency 1

Interventions

Minocycline 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2/3 × cyclopia sequence × CNS × Clear all
NCT01813240 2013-03-18

Prevention of Imminent Paralysis Following Spinal Cord Trauma or Ischemia by Minocycline: A Multi-center Study in Israel With IDF Primary Care Involvement

Hadassah Medical Organization

Phase 2/3 Unknown
444 enrolled
CNS

cyclopia sequence, Spinal Cord Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡